All tools and calculators

Compare stocks

Evaluate stocks side by side, to find the best fit for your investment goals.
View stock
VS
AbbVie is a pharmaceutical firm with a strong exposure to immunology (with Humira, Skyrizi, and Rinvoq) and oncology (with Imbruvica and Venclexta). The company was spun off from Abbott in early 2013. The 2020 acquisition of Allergan added several new products and drugs in aesthetics, including Botox. The 2024 acquisitions of Cerevel (neuroscience) and ImmunoGen (oncology) help supplement AbbVie's portfolio.
View stock

Stock highlights

Stock comparison highlights
Stock name
Richter Gedeon Nyrt.AbbVie
Last price
Ft 12,830$294.79
Currency
HUF
USD
Ft 2.389T$514B
11.1982.15
Ft 1,180$3.54
0.340.28
Ft 655$6.83
4.96%2.38%
Sector
HealthHealth
Employees
11,15557,000
Ticker
Ft RICHTER$ABBV
Primary listing
BUXNYSE

Performance

CumulativeRolling yearsLump sum investment

Invest in FtRICHTER or $ABBV on Lightyear

Save on broker fees and invest in 6000+ stocks and funds. When you invest, your capital is at risk.
Sign up